Recent medical studies highlight advances in microbiome health, targeted treatments reducing steroid dependency, and emerging infection and mental health risks.
Key Points
Research indicates that prebiotic fiber like inulin can help gut microbial communities in ulcerative colitis patients resist C difficile colonization by boosting short-chain fatty acid production.
A nutritional supplement containing oxaloacetate has shown promise in improving cognitive difficulties experienced by breast cancer survivors following their treatment.
Interleukin-5 inhibitors are associated with faster corticosteroid tapering and eventual discontinuation in patients suffering from drug reaction with eosinophilia and systemic symptoms (DRESS).
A post hoc analysis reveals that using belimumab alongside standard therapy for systemic lupus erythematosus reduces glucocorticoid use and minimizes organ damage over an eight-year period.
National survey data shows that more than 40 percent of US individuals aged 14 to 59 with Mycoplasma genitalium infections carry macrolide-resistant strains.
A study on routinely tested Asian American patients finds that while tuberculosis test conversion is generally uncommon, travel to higher-prevalence countries nearly doubles the odds.
Children and adolescents with intellectual developmental disorders face a significantly higher risk of developing incident depression and anxiety compared to their peers.
An online survey of Greek parents indicates that over half report a suspected food allergic reaction in their preschooler, with cow's milk being the most frequently blamed culprit.